MENU
SNTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Senti Biosciences (SNTI) Ownership - Who owns Senti Biosciences?

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases... Show more

Profile

Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
26.55M
P/E Ratio
4.27
Total Cash
12.24M
Projected Growth
N/A
Total Debt
30.12M
Revenue
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SNTI
Capitalization
26.6M
P/E Ratio
4.27
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
12.2M
Total Cash/Share
0.47
Total Debt
30.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
8.12M
P/B Ratio
3.27
Cash Flow
N/A
Earnings
-2.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
1.51
Current Revenue Per Employee
2090.16
Dividends Per Share - Security
N/A
EBITDA
-60.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-86.19
Shares Held By Institutions
9.12M
Shares Outstanding - Current
26.3M
Total Liabilities
44.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-2.885
View a ticker or compare two or three
SNTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com